The synthesis of a new PEG-solubilized gadolinium texaphyrin (Gd-Tex) conjugate containing a malonate-Pt(NH(3))(2) moiety is described. The effect of the tumor localizing Gd-Tex macrocycle on platinum activity was evaluated in cell culture. The malonate moiety, analogous to that present in carboplatin, is expected to release an aquated Pt(NH(3))(2) species under physiological conditions. The half-life in phosphate-buffered saline was found to be ca. 3 days at room temperature, and the hydrolytic product released from the conjugate was collected and confirmed as Pt-based by flameless atomic absorption spectrophotometry. Anti-proliferative activity was tested using A549 human lung cancer and A2780 human ovarian cancer cell lines. In both cell lines, the activity of the Gd-Tex conjugate was found to be similar to that of carboplatin. Efficacy against a Pt-resistant ovarian cell line greater than that displayed by carboplatin was also observed.
The synthesis of a new PEG-solubilized n class="Chemical">gadolinium texaphyrin (Gd-Tex) conjugate containing a malonate-Pt(NH(3))(2) moiety is described. The effect of the tumor localizing Gd-Tex macrocycle on platinum activity was evaluated in cell culture. The malonate moiety, analogous to that present in carboplatin, is expected to release an aquated Pt(NH(3))(2) species under physiological conditions. The half-life in phosphate-buffered saline was found to be ca. 3 days at room temperature, and the hydrolytic product released from the conjugate was collected and confirmed as Pt-based by flameless atomic absorption spectrophotometry. Anti-proliferative activity was tested using A549 human lung cancer and A2780 human ovarian cancer cell lines. In both cell lines, the activity of the Gd-Tex conjugate was found to be similar to that of carboplatin. Efficacy against a Pt-resistant ovarian cell line greater than that displayed by carboplatin was also observed.
Authors: S W Young; F Qing; A Harriman; J L Sessler; W C Dow; T D Mody; G W Hemmi; Y Hao; R A Miller Journal: Proc Natl Acad Sci U S A Date: 1996-06-25 Impact factor: 11.205
Authors: R A Miller; K Woodburn; Q Fan; M F Renschler; J L Sessler; J A Koutcher Journal: Int J Radiat Oncol Biol Phys Date: 1999-11-01 Impact factor: 7.038
Authors: S W Young; M K Sidhu; F Qing; H H Muller; M Neuder; G Zanassi; T D Mody; G Hemmi; W Dow; J D Mutch Journal: Invest Radiol Date: 1994-03 Impact factor: 6.016
Authors: L R Kelland; G Abel; M J McKeage; M Jones; P M Goddard; M Valenti; B A Murrer; K R Harrap Journal: Cancer Res Date: 1993-06-01 Impact factor: 12.701
Authors: Christian Preihs; Jonathan F Arambula; Vincent M Lynch; Zahid H Siddik; Jonathan L Sessler Journal: Chem Commun (Camb) Date: 2010-10-04 Impact factor: 6.222
Authors: Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler Journal: Anticancer Agents Med Chem Date: 2011-02 Impact factor: 2.505
Authors: Grégory Thiabaud; Guangan He; Sajal Sen; Kathryn A Shelton; Wallace B Baze; Luke Segura; Julie Alaniz; Ruben Munoz Macias; Greg Lyness; Alan B Watts; Hyun Min Kim; Hyunseung Lee; Mi Young Cho; Kwan Soo Hong; Rick Finch; Zahid H Siddik; Jonathan F Arambula; Jonathan L Sessler Journal: Proc Natl Acad Sci U S A Date: 2020-03-16 Impact factor: 11.205
Authors: Christian Preihs; Jonathan F Arambula; Darren Magda; Heeyeong Jeong; Dongwon Yoo; Jinwoo Cheon; Zahid H Siddik; Jonathan L Sessler Journal: Inorg Chem Date: 2013-04-04 Impact factor: 5.165